Characterizing the Economic Analysis of Technology Appraisal in Global Health Systems

Loading...
Thumbnail Image
Penn collection
Summer Program for Undergraduate Research (SPUR)
Degree type
Discipline
Subject
Comparative Effectiveness Research
Pharmacoeconomics
Health Technology Assessment
cost-effective analysis
outcomes research
Business
Econometrics
Health Economics
Funder
Grant number
License
Copyright date
Distributor
Related resources
Contributor
Abstract

Global Health Technology Assessment (HTA) bodies vary in their scope and approach in Cost Effective Analyses (CEA) evaluating the clinical and economic efficacy of a proposed therapeutic against established metrics. This study characterized specific CEA approaches of various countries across standardized development indices and tested conditions of regression correlation against respective country health outcomes of interest. Additionally, we validate the existence of implicit and explicit values in country willingness-to-pay (WTP) thresholds and its statistically significance with country health expenditure and quality of care. Our multivariate regression models show that while CEA characteristics vary across countries, ultimate health outcomes are not dictated by CEA approach factors but rather in the broader context of country GDPPC development.

Advisor
Abby Alpert
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2018-01-01
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
Recommended citation
Collection